Stada is poised to expand its consumer health product offering in the US with the launch of histamine intolerance dietary supplement Histasolv.
The company’s US partner NexGel plans to begin marketing Histasolv direct to consumers in the third quarter of this year.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?